Cyclerion Therapeutics
CYCN
CYCN
80 hedge funds and large institutions have $49.1M invested in Cyclerion Therapeutics in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 22
Holders
80
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.17M | |
| 2 | +$2.49M | |
| 3 | +$2.47M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.8M |
| 5 |
AG
Artal Group
Luxembourg
|
+$1.32M |
Top Sellers
| 1 | -$952K | |
| 2 | -$702K | |
| 3 | -$492K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$471K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$379K |